Division of Health Chemistry, Department of Healthcare and Regulatory Sciences, School of Pharmacy, Showa University, Tokyo, Japan.
Division of Biological Chemistry, Department of Molecular Biology, School of Pharmacy, Showa University, Tokyo, Japan.
FEBS J. 2018 Jun;285(11):2056-2070. doi: 10.1111/febs.14462. Epub 2018 Apr 18.
Chemokines are secreted proteins that regulate cell migration and are involved in inflammatory and immune responses. Here, we sought to define the functional crosstalk between the lipid signaling and chemokine signaling. We obtained evidence that the induction of some chemokines is regulated by group VIA calcium-independent phospholipase A β (iPLA β) in IL-1β-stimulated rat fibroblastic 3Y1 cells. Treatment of 3Y1 cells with IL-1β elicited an increased release of chemotactic factor(s) for monocytic THP-1 cells into culture medium in a time-dependent manner. Inhibitor studies revealed that an intracellular PLA inhibitor, arachidonoyl trifluoromethyl ketone (AACOCF ), but not the cyclooxygenase inhibitor indomethacin, attenuated the release of chemotactic factor(s). The chemotactic activity was inactivated by treatment with either heat or proteinase K, suggesting this chemotactic factor(s) is a proteinaceous factor(s). We purified the chemotactic factor(s) from the conditioned medium of IL-1β-stimulated 3Y1 cells using a heparin column and identified several chemokines, including CCL2 and CXCL10. The inducible expressions of CCL2 and CXCL10 were significantly attenuated by pretreatment with AACOCF . Gene silencing using siRNA revealed that the inductions of CCL2 and CXCL10 were attenuated by iPLA β knockdown. Additionally, the transcriptional activation of nuclear factor of activated T-cell proteins (NFATs), but not nuclear factor-κB, by IL-1β stimulation was markedly attenuated by the iPLA inhibitor bromoenol lactone, and NFATc4 knockdown markedly attenuated the IL-1β-induced expression of both CCL2 and CXCL10. Collectively, these results indicated that iPLA β plays roles in IL-1β-induced chemokine expression, in part via NFATc4 signaling.
趋化因子是分泌蛋白,可调节细胞迁移,并参与炎症和免疫反应。在这里,我们试图定义脂质信号和趋化因子信号之间的功能串扰。我们获得的证据表明,在 IL-1β 刺激的大鼠成纤维细胞 3Y1 细胞中,某些趋化因子的诱导受组 VIA 钙非依赖性磷脂酶 Aβ(iPLAβ)调节。用 IL-1β 处理 3Y1 细胞会在时间依赖性方式下增加趋化因子(s)释放到培养基中,以吸引单核细胞 THP-1 细胞。抑制剂研究表明,细胞内 PLA 抑制剂,花生四烯酰三氟甲基酮(AACOCF),而不是环氧化酶抑制剂吲哚美辛,可减弱趋化因子(s)的释放。趋化活性被热或蛋白酶 K 处理失活,表明这种趋化因子(s)是蛋白质因子(s)。我们使用肝素柱从 IL-1β 刺激的 3Y1 细胞的条件培养基中纯化趋化因子(s),并鉴定了几种趋化因子,包括 CCL2 和 CXCL10。AACOCF预处理显著减弱了 CCL2 和 CXCL10 的诱导表达。使用 siRNA 进行基因沉默表明,iPLAβ 敲低减弱了 CCL2 和 CXCL10 的诱导。此外,IL-1β 刺激引起的 T 细胞激活核因子(NFATs)的转录激活,但不是核因子-κB,被 iPLA 抑制剂溴烯醇内酯显著减弱,并且 NFATc4 敲低显著减弱了 IL-1β 诱导的 CCL2 和 CXCL10 的表达。总的来说,这些结果表明 iPLAβ 在 IL-1β 诱导的趋化因子表达中发挥作用,部分通过 NFATc4 信号转导。